Celgene International SarlAugust 7th, 2017
FiledAugust 7th, 2017CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉ STUDII for Protocol GED-0301-CD-003 pro protokol GED-0301-CD-003 This Clinical Trial Agreement (hereinafter, the “Agreement”) is by and between: Tato smlouva o klinické studii (dále jako „smlouva“) byla uzavřena mezi: Celgene Corporation, having its principal office at 86 Morris Avenue, Summit, NJ 07901, USA (hereinafter the “Sponsor”) represented for the purposes of this Agreement by Celgene International S.à.r.l, a limited liability company organized under the laws of Switzerland having its principal office at Route de Perreux, 2017 Boudry, Switzerland and for the purposes of signing this Agreement represented by Quintiles Czech Republic s.r.o., having a place of business at Radlicka 714/113a, 158 00 Praha 5, CzechRepublic, IČ: 247 68 651, DIČ: CZ247 68 651; Celgene Corporation, se sídlem 86 Morris Avenue, Summit, NJ 07901, USA (dále uváděna jako„zadavatel“), pro účely této smlouvy zastoupená Celgene International S.à.r.l, společností s ruč